Cargando…
Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus
INTRODUCTION: Antiphospholipid antibodies (aPL) affect atherogenesis and may cause thromboembolism in systemic lupus erythematosus (SLE) and coronary artery disease (CAD). Intensive treatment with statins may reduce inflammation and decrease the number of thrombotic events. That may explain the bene...
Autores principales: | Mazurek, Adam, Gryga, Krzysztof, Bugala, Kamil, Iwaniec, Teresa, Musial, Jacek, Podolec, Piotr, Plazak, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826879/ https://www.ncbi.nlm.nih.gov/pubmed/35154521 http://dx.doi.org/10.5114/aoms.2019.90271 |
Ejemplares similares
-
Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
por: Plazak, Wojciech, et al.
Publicado: (2011) -
Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
por: Dziedzic-Oleksy, Hanna, et al.
Publicado: (2022) -
Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients
por: Plazak, Wojciech, et al.
Publicado: (2011) -
Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients
por: Plazak, Wojciech, et al.
Publicado: (2011) -
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)